Hope or hype in the treatment of schizophrenia - what's the role of the physician?

Show simple item record

dc.contributor.author Bressan, Rodrigo A. [UNIFESP]
dc.contributor.author Grohs, Geder E. M.
dc.contributor.author Matos, Gabriela [UNIFESP]
dc.contributor.author Shergill, Sukhi [UNIFESP]
dc.date.accessioned 2020-07-02T18:52:06Z
dc.date.available 2020-07-02T18:52:06Z
dc.date.issued 2018
dc.identifier http://dx.doi.org/10.1192/bjp.2017.13
dc.identifier.citation British Journal Of Psychiatry. London, v. 212, n. 1, p. 1-3, 2018.
dc.identifier.issn 0007-1250
dc.identifier.uri https://repositorio.unifesp.br/handle/11600/53880
dc.description.abstract According to the experience of people with schizophrenia, their psychiatrists' attitude towards the outcome of their illness is lacking in hope, which directly affects mutual faith in treatment. Here we discuss the scientific basis of hope and show its instrumental role in optimising the best treatment strategies for schizophrenia. en
dc.description.sponsorship Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brasil
dc.description.sponsorship Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brasil
dc.description.sponsorship Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasil
dc.description.sponsorship European Research Council Consolidator Award
dc.description.sponsorship National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London
dc.format.extent 1-3
dc.language.iso eng
dc.publisher Royal Coll Psychiatrists
dc.relation.ispartof British Journal Of Psychiatry
dc.rights Acesso aberto
dc.title Hope or hype in the treatment of schizophrenia - what's the role of the physician? en
dc.type Editorial
dc.description.affiliation Univ Fed Sao Paulo, PROESQ Schizophrenia Program, Sao Paulo, Brazil
dc.description.affiliation Univ Fed Sao Paulo, LiNC Interdisciplinary Lab Clin Neurosci, Sao Paulo, Brazil
dc.description.affiliation Psychiat Residency IPqSC SES, Schizophrenia Program, Santa Catarina, Brazil
dc.description.affiliation Janssen Cilag Farmaceut, Sao Paulo, Brazil
dc.description.affiliationUnifesp Univ Fed Sao Paulo, PROESQ Schizophrenia Program, Sao Paulo, Brazil
dc.description.affiliationUnifesp Univ Fed Sao Paulo, LiNC Interdisciplinary Lab Clin Neurosci, Sao Paulo, Brazil
dc.description.sponsorshipID FAPESP: 2016/02246-5
dc.description.sponsorshipID European Research Council Consolidator Award: 311686
dc.identifier.file WOS000424204000001.pdf
dc.identifier.doi 10.1192/bjp.2017.13
dc.description.source Web of Science
dc.identifier.wos WOS:000424204000001
dc.coverage London
dc.citation.volume 212
dc.citation.issue 1



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account